Improving treatment for HIV and opioid use disorder with long-acting injections
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder
This study is looking at how combining long-acting injectable treatments for both HIV and opioid use disorder can make it easier for people to stick to their medications and improve their health, so if you’re living with both conditions, this research might be for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10795911 on NIH RePORTER |
What this research studies
This research investigates how to better integrate treatment for individuals living with both HIV and opioid use disorder (OUD) by using long-acting injectable medications. The approach focuses on combining HIV and OUD treatments into a single care model to enhance medication adherence and improve health outcomes. By utilizing new injectable therapies, the study aims to reduce the burden of daily pill-taking, which can be a barrier for many patients. The research will explore the acceptability, feasibility, and safety of this integrated treatment approach across different populations and settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with both HIV and opioid use disorder who may benefit from integrated treatment approaches.
Not a fit: Patients who are not living with HIV or opioid use disorder may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence and health outcomes for patients living with both HIV and opioid use disorder.
How similar studies have performed: Previous studies have shown promise in integrating treatments for HIV and OUD, suggesting that this approach could be effective.
Where this research is happening
Providence, United States
- Rhode Island Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Langdon, Kirsten Johnson — Rhode Island Hospital
- Study coordinator: Langdon, Kirsten Johnson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.